BiotechTube
Home/Medigene/Prof. Dr. Dolores J. Schendel
PD

Prof. Dr. Dolores J. Schendel

Chief Executive Officer & Chief Scientific Officer

Medigene

Therapeutic Areas

Oncology

Medigene Pipeline

DrugIndicationPhase
MDG1011Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Multiple Myeloma (MM)Phase I/II
MDG1021Solid TumorsPreclinical
TCR Library ProgramVarious Solid TumorsDiscovery

Leadership Team at Medigene

DS
Dr. Selwyn Ho
Chief Financial Officer
DK
Dr. Kirsten Richter
Chief Development Officer
DT
Dr. Thomas Widmann
Chief Legal Officer
DK
Dr. Kai Pinkernell
Chief Medical Officer
DK
Dr. Kristina Rübsamen-Schaeff
Chairperson of the Supervisory Board
View full Medigene profile